Showing results (161-170 of 1,969) with videos related to
Sort By:
Pageof 197
Current Pharmaceutical Design|March 8, 2011
The gp130 receptor cytokine family: regulators of adipocyte development and functionUrsula A White, Jacqueline M StephensVaccines|April 16, 2020
Function and Modulation of Type I Interferons during Respiratory Syncytial Virus InfectionLaura M Stephens, Steven M VargaClinical and Experimental Pharmacology & Physiology|September 1, 1981
Psychosocial stress induces tubulointerstitial nephritis unrelated to hypertension in CBA miceJ P Henry, P M StephensThe Journal of Biological Chemistry|December 26, 2001
Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytesZ Elizabeth Floyd, Jacqueline M StephensObesity Research|July 2, 2004
Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylationZ Elizabeth Floyd, Jacqueline M StephensDiabetes|June 29, 2005
The regulation of fatty acid synthase by STAT5AJessica C Hogan, Jacqueline M StephensBlood|July 28, 2021
Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignanciesDeborah M Stephens, John C ByrdOncology (Williston Park, N.Y.)|January 22, 2013
Chronic lymphocytic leukemia with del(17p13.1): a distinct clinical subtype requiring novel treatment approachesDeborah M Stephens, John C ByrdHematology/Oncology Clinics of North America|April 9, 2013
Improving the treatment outcome of patients with chronic lymphocytic leukemia through targeted antibody therapyDeborah M Stephens, John C ByrdPageof 197